Reaven J, Hepburn S.  2006.  The Parent’s Role in the Treatment of Anxiety Symptoms in Children with High-Functioning Autism Spectrum Disorders. Mental Health Aspects of Developmental Disabilities. 9(3):73-80.

Hillman J.  2006.  Supporting and Treating Families With Children On The Autistic Spectrum: The Unique Role Of The Generalist Psychologist. Psychotherapy: Theory, Research, Practice, Training. 43(3):349-358.

Wasserman S, Iyengar R, Chaplin WF, Watner D, Waldoks SE, Anagnostou E, Soorya L, Hollander E.  2006.  Levetiracetam Versus Placebo in Childhood and Adolescent Autism: A Double-Blind Placebo-Controlled Study. International Clinical Psychopharmacology. 21(6):363-367.

Kapetanovic S, Simpson GM.  2006.  Review of Antipsychotics in Children and Adolescents. Expert Opin. Pharmacother. 7(14):1871-85.

Legoff DB, Sherman M.  2006.  Long-term Outcome of Social Skills Intervention Based on Interactive LEGO® Play. Autism. 4:317-329.

Giannotti F, Cortesis F, Cerquiglini A, Bernabei P.  2006.  An Open-Label Study of Controlled-Release Melatonin in Treatment of Sleep Disorders in Children with Autism. J Autism Dev Disord. 36(6):741-52.

Canitano R.  2006.  Self Injurious Behavior in Autism: Clinical Aspects and Treatment with Risperidone. J. Neural Transm. 113(3):425-31.

Zimbelman M, Paschal A, Hawley SR, Molgaard CA, StRomain T.  2006.  Addressing Physical Inactivity Among Developmentally Disabled Students Through Visual Schedules and Social Stories. Res Dev Disabil. (Epub ahead of print).

Pumariega AJ.  2006.  Residential Treatment for Youth: Introduction and Cautionary Tale. American Journal of Orthopsychiatry. 76(3):281-284.

Adams JB, George D, Audhya T.  2006.  Abnormally High Plasma Levels of Vitamin B6 in Children with Autism not Taking Supplements Compared to Controls not Taking Supplements. Journal of Alternative and Complementary Medicine. 12:59-63.

Stromer R, Kimball JW, Kinney EM, Taylor BA.  2006.  Activity Schedules, Computer Technology, and Teaching Children with Autism Spectrum Disorders. Focus on Autism and Other Developmental Disabilities. 21(1):14-24.

Stichter JP, Brown T, Clarent R, Iskow J, Krug M, Richards J.  2006.  Addressing the Challenges: Developing a Programmatic Framework for the Systematic Integration of Evidence-based Practices for Young Children with Autism Spectrum Disorder. Beyond Behavior. 16(1):18-32. Abstract

Yao Y, Walsh WJ, McGinnis WR, Pratico D.  2006.  Altered Vascular Phenotype in Autism: Correlation with Oxidative Stress. Arch Neurol.. 63(8):1161-1164.

Kuhn S, Lerman DC, Vorndran ACM, Addison L.  2006.  Analysis of Factors that Affect Responding in a Two-Response Chain in Children with Developmental Disabilities. Journal of Applied Behavior Analysis. 39:263-280.

Deshpande C, Dhir A, Kulkarni SK.  2006.  Antagonistic Activity of Ascorbic Acid (Vitamin C) on Dopaminergic Modulation: Apomorphone-Induced Stereotypic Behavior in Mice. Pharmacology. 77:38-45.

Allain H, Bentue-Ferrer D.  2006.  The Anti-Dementia Drugs: Myth, Hype or Reality? Clin Neuropharmacol. 29(1):10-14.

Shastri M, Alla L, Sabaratnam M.  2006.  Aripiprazole Use in Individuals with Intellectual Disability and Psychotic or Behavioral Disorders: A Case Series. Journal of Psychopharmacology. 20(6):863-867.

Baskin JH, Sperber M, Price BH.  2006.  Asperger Syndrome Revisited. Reviews in Neurological Diseases. 3(1):1-7.

McPartland J, Klin A.  2006.  Asperger’s Syndrome. Adolescent Medicine Clinics. 17(3):771-788.

Oneal BJ, Reeb RN, Korte JR, Butter EJ.  2006.  Assessment of Home-Based Behavior Modification Programs for Autistic Children: Reliability and Validity of the Behavioral Summarized Evaluation. Journal of Prevention and Intervention in the Community. 32(1-2):25-39.

Troost PW, Steenhuis M-P, Tuynman-Qua HG, Kalverdijk LJ, Buitelaar JK, Minderaa RB, Hoekstra PJ.  2006.  Atomoxatine for Attention-Deficit/Hyperactivity Disorder Symptoms in Children with Pervasive Developmental Disorders: A Pilot Study. Journal of Child and Adolescent Psychopharmacology. 16(5):611-619.

Arnold LE, Cook MG, Witwer AM, Hall KL, Thompson S, Ramadan Y.  2006.  Atomoxetine for Hyperactivity in Autism Spectrum Disorders: Placebo-Controlled Crossover Pilot Trial. J. Am. Acad. Child Adolesc.. 45(10):1196-1205.

Niederhofer H.  2006.  Atomoxetine Treating Patients with Autistic Disorder. Autism. 10(6):647-650.

Niederhofer H.  2006.  Atomoxetine: Treating Patients with Autistic Disorder. Autism. 10(6):647-650.

Sinha Y, Silove N, Wheeler D, Williams K.  2006.  Auditory Integration Training and Other Sound Therapies for Autism Spectrum Disorders: A Systematic Review. Arch Dis Child. 91(12):1018-1022.